Vero Combines Stanford’s Proteomic Organ and Cell Aging Technologies to Build a New Clinical and Consumer Tool for Predictive Health
Higher-resolution biological aging insights predict disease earlier and guide more targeted interventions CORTE MADERA, Calif. — Vero, a predictive health company on a mission to end age-related chronic disease, today…